Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults

NCT02344290 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7769

Enrollment

NIH

Sponsor class

Conditions

HIV
Cardiovascular Diseases

Interventions

DRUG: Pitavastatin
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]